Tolvaptan and Number Needed to Harm in Autosomal Dominant Polycystic Kidney Disease

相似书籍

• Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update
  由: Matt Gittus, et al.
  出版: (2025-02-01)
• Tolvaptan: a possible preemptive treatment option in children with autosomal dominant polycystic kidney disease?
  由: Hee Sun Beak, et al.
  出版: (2023-12-01)
• Compassionate use of tolvaptan in acquired megacolon secondary to autosomal dominant polycystic kidney disease (ADPKD)
  由: Iris Viejo Boyano, et al.
  出版: (2024-03-01)
• Pelvic organ prolapse in women with autosomal dominant polycystic kidney disease under tolvaptan treatment
  由: Cristina Sango, et al.
  出版: (2023-11-01)
• The safety and efficacy of tolvaptan in the treatment of patients with autosomal dominant polycystic kidney disease: A systematic review and meta-analysis
  由: Xuanwei Li, et al.
  出版: (2023-11-01)